Pediatrics Food Allergies by Bayer, Diana, MD
Pediatric Allergy
Diana K. Bayer, DO
Pediatric Allergy/Immunology
University of Iowa Children’s Hospital
April 16, 2015
Urticaria, Angioedema, Anaphylaxis
Anaphylaxis by 2 mechanisms: 
 IgE-mediated
 Non-IgE-mediated
 Opiates, muscle relaxants, vancomycin, radiocontrast medium
 NSAIDs (e.g. ibuprofen, naproxen, etc.) 
 Due to IgE & non-IgE-mediated mechanisms
 Common Causes:
 Foods: 
90% of food-related allergic reactions due to 8 foods (cow’s milk, egg, soy, 
wheat, peanuts, tree nuts, fish, and shellfish) 
 Drugs: 
 Antibiotics (penicillin, cephalosporins, non-beta-lactams)
Urticaria, Angioedema, Anaphylaxis
 Common Causes:
 Insect venom
 Normal reactions: transient, localized pain or itching
 Large local reaction: marked erythema & swelling that peaks at 24-48 hrs, often involve 
entire extremity or cross joint, & resolve in 3-10 days with no sequelae
 IgE-mediated
 Increased risk for future anaphylaxis with subsequent stings (~5-10%) 
 Tx: symptomatic care. Frequently misdiagnosed (& tx’ed) as cellulitis
 Latex
 up to 75% with spina bifida & 10-15% healthcare workers
 Vaccines (0.65 / 1 million doses)
 Latex in vial stoppers, neomycin, gelatin, egg
 Egg allergy
 NOT a contraindication for MMR vaccine
 Contraindicated: yellow fever vaccine and live intranasal influenza vaccine
 Injectable single-dose vial influenza vaccine (“Fluzone”) should be given in 
an allergy/immunology physician's office with 30 minute observation period. 
Acute urticaria
 Acute urticaria (<6 weeks): 
 More likely to have an identifiable etiology than chronic urticaria
 Viral or bacterial infections: most common cause (> 80%)
 Particularly in children
 If angioedema with NO urticaria, consider hereditary angioedema: 
 occurs at sites of trauma or around the mouth and extremities
 +/- preceded by a transient, serpiginous rash
 +/- abdominal cramping suggesting bowel edema
 occurs with a family history of similar symptoms
 requires prolonged treatment
Urticaria, Angioedema, Anaphylaxis
Chronic urticaria
 Recurrent hives on most days of the week for > 6 weeks
 Causes
 Idiopathic (80-90%)
 AutoAb vs IgE (30-50%)
 Physical (~5%)
 Dermatographism
 Heat-induced
 Cold-induced (e.g to water or air)
 Delayed-pressure
 Solar
Does NOT warrant allergy testing
1st line treatment: 2nd generation (long-acting) H1 antihistamine
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Chronic Urticaria
1st line treatment: 2nd generation (long-acting) H1 antihistamine
 e.g. cetirizine, levocetirizine, fexofenadine, loratadine, desloratadine
 Effective & better tolerated than 1st generation (short-acting) H1 antihistamines 
 ↓ sedative and anticholinergic effects than older 1st generation H1 antihistamines 
 E.g. diphenhydramine, hydroxyzine
 50% to 95% of patients achieve satisfactory disease control  ≥1 oral 
antihistamines
 1st generation (short-acting) H1 antihistamines (eg, diphenhydramine, 
hydroxyzine): 
 Sedation
 Anticholinergic adverse effects
 Performance impairment
 Frequent dosing
 Paradoxical agitation
 Inadvertent overdosing
Chronic Urticaria
 H2 antihistamines (eg, ranitidine and cimetidine): 
 NOT effective monotherapy
 Systemic glucocorticoids: 
 Effective in controlling symptoms, but symptoms recur as glucocorticoids 
tapered or discontinued. 
 NOT alter the long-term course of the disease
 Immunosuppressive medications (steroid-sparing)
 Anti-IgE monoclonal Ab (omalizumab, or “Xolair”)
Chronic Urticaria
Other factors to consider:
 Underlying infection
 Autoimmune etiology
 Fever, weight loss, arthralgias, & other constitutional symptoms
 Vasculitic
 Duration of lesions >72 hours
 Pain
 Discoloration (Hyperpigmentation)
 Residual scarring
 Familial pattern/ Hereditary syndromes
 Thyroid disease (Hashimoto, Graves)
 Association with malignant tumor
Anaphylaxis: Diagnosis
Anaphylaxis is highly likely when any 1 of the following 
3 criteria fulfilled:
Criterion 1: Acute onset of an illness (min to hrs) with involvement of 
the skin, mucosal tissue, or both (eg, generalized hives, pruritus or 
flushing, swollen lips-tongue-uvula)   
AND ≥1 OF THE FOLLOWING:
Respiratory compromise (eg, dyspnea, wheeze-bronchospasm, 
stridor, hypoxemia)
Reduced BP* or associated symptoms of end-organ 
dysfunction (eg, hypotonia, collapse, syncope, incontinence)
Anaphylaxis: Diagnosis
Anaphylaxis is highly likely when any 1 of the 
following 3 criteria fulfilled:
- Criterion 2: ≥2 OF THE FOLLOWING that occur rapidly after 
exposure to a LIKELY allergen for that patient (minutes to 
several hours):
 Involvement of the skin-mucosal tissue (eg, generalized hives, 
itch-flush, swollen lips-tongue-uvula)
 Respiratory compromise (eg, dyspnea, wheeze-bronchospasm, 
stridor, hypoxemia)
 Reduced BP* or associated symptoms (eg, hypotonia, collapse, 
syncope, incontinence)
 Persistent GI symptoms (eg, crampy abdominal pain, vomiting, 
diarrhea)
Anaphylaxis: Diagnosis
Anaphylaxis is highly likely when any 1 of the 
following 3 criteria fulfilled:
Criterion 3: Reduced BP* after exposure to a KNOWN allergen 
for that patient (min to hrs):
 Infants and children - Low systolic BP (age-specific)* or greater than 30 
percent decrease in systolic BP
 Adults - Systolic BP <90 mmHg or greater than 30 percent decrease from 
that person's baseline
Anaphylaxis
 Frequency of Signs/Symptoms: 
 Cutaneous (85 – 90%)
 Upper Airway Angioedema (50-60%)
 Dyspnea, Wheeze (40 – 50%)
 Dizziness, Syncope, Hypotension (30-35%)
 Abdominal (25-30%)
 Prior episodes of anaphylaxis do not predict future episodes 
of anaphylaxis.
Question 1
A 2-year-old girl presented to the urgent care center for rash
and swelling of her lips. 
While visiting a neighbor, the girl took a few bites of a peanut 
butter cracker and started coughing. 
The mother initially thought that her daughter had choked on 
the cracker, but then noticed that the girl had developed hives 
on her face. 
The mother wiped her daughter’s face and mouth and gave 
her a teaspoon of diphenhydramine. 
The hives began to fade, but the girl then developed lip 
swelling and a raspy voice. She became progressively 
irritable and now appears to be breathing fast.
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Of the following, the MOST appropriate step in 
this girl’s management is to administer
A. injectable corticosteroid
B. injectable epinephrine
C. nebulized albuterol
D. ranitidine and 
diphenhydramine
E. scheduled 
diphenhydramine
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Anaphylaxis: Treatment
 Resolution of anaphylaxis may occur in: 
 Uniphasic: min to hours
 Biphasic
 Recurrence after initial improvement of symptoms
 ~20% experience 2-24 hrs after initial reaction
 Protracted resolution
 Epinephrine: administer promptly at the onset of symptoms suggestive of 
anaphylaxis
 Epinephrine is life-saving:
 α-adrenergic vasoconstrictor effects in most body organ systems
 Prevent and relieve airway obstruction
 β-adrenergic inotropic and chronotropic properties on the heart
 Decrease mediator release from mast cells
Anaphylaxis: Treatment
 2nd line treatment options in the outpatient setting: 
 Antihistamines
 β2-agonists
 Glucocorticoids
 Antihistamines (both H1 and H2 blockers)
 Should NEVER be used alone for anaphylaxis treatment 
 Given AFTER epinephrine administration 
 Glucocorticoids
 Potential to prevent the biphasic reaction & recurrent/protracted anaphylaxis
 β2-agonists (inhaled albuterol) 
 Can improve bronchospasm
 NOT alter the course of the reaction
Anaphylaxis: Treatment
1) Epinephrine: initial/immediate medication
• 0.01 mg/kg (maximum initial dose: 0.5 mg)
• Current epinephrine injectors are available in 2 strengths (doses): 
0.15 mg and 0.30 mg
• 10-20% of pts may require 2nd dose epinephrine
2) CALL 911 for EMS transport to ER!
3) H1 oral antihistamines (e.g. Benadryl)
4) Albuterol - if history of asthma
• Corticosteroid
• H2 oral antihistamine
• Rx: EpiPen 2-pack 
• May require 2nd dose epinephrine in 5-10 min after 1st dose
• Education - indications & technique
www.FoodAllergy.org
Food Allergy
 Food allergy: 
 Most common cause of anaphylaxis in home or school setting
 50% of all pediatric cases of anaphylaxis annually
 85% to 90% of allergic reactions to food in children –
due to the 8 most common food allergens: 
 milk, egg, soy, wheat, peanuts, tree nuts, fish, and 
shellfish
Food Allergy
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Food Allergy
 > 90% of food-allergic individuals demonstrate clinical responses 
to only 1 or 2 foods
 Peanut allergy 
 ≤ 50% of children with peanut allergy may develop tree nut allergies
 In westernized countries:
 Milk allergy: most common food allergen in infants (2.5%)
 Egg allergy (1.5%) 
Food Allergies & Atopic Dermatitis
 National Institute of Allergy and Infectious Diseases (NIAID) food allergy guidelines 
recommend children <5yo with moderate to severe atopic dermatitis (AD) be 
considered for food allergy evaluation for milk, egg, wheat, soy, and nuts, if at least 1 
of the following conditions is met: 
(a) persistent AD despite optimized management and topical therapy 
OR 
(b) reliable history of an immediate reaction after ingestion of a specific food
 ~30% to 40% of infants with moderate-to-severe AD may have an underlying 
IgE-mediated food allergy exacerbating the AD and should undergo food allergy 
testing
Diagnosis & Treatment of Allergic Disease: 
Skin testing
 Allergy skin testing: more sensitive & specific than blood testing
 Indications for immediate-type skin testing
 Identification of aeroallergen triggers in patients who have asthma
 ~ 60% of children with persistent asthma have coexisting allergic rhinitis
 Allergic rhinitis that is not controlled with usual medications or if allergen 
avoidance is desired
 Allergies to seasonal environmental allergens typically do not develop until ≥3 years of age.
 Food allergy
 Insect sting allergy
 Vaccine, drug, or latex allergy
 Evaluation for moderate-to-severe atopic dermatitis
 Other conditions: allergic fungal sinusitis, allergic bronchopulmonary 
aspergillosis, and eosinophilic esophagitis
** Discontinue oral antihistamines 5 days prior to initial evaluation. 
** Skin testing may only be performed ≥6 weeks from anaphylaxis. 
Diagnosis & Treatment of Allergic Disease: 
in vitro testing
 Clinicians who obtain specific IgE to a specific allergen 
should be comfortable with interpretation and application of 
test results for specific clinical scenarios 
 Age-specific IgE values are utilized in interpretation of the most 
common food allergens – not class I-V as included in 
interpretation of many commercial lab results
 Do NOT recommend obtain serum specific IgE values for foods 
prior to allergy/immunology evaluation
Pediatric Allergy/Immunology
 Food allergy
 Anaphylaxis
 Angioedema
 Allergic rhinitis (“seasonal allergies”, “hayfever”)
 Insect venom allergy
 Drug allergy
 Eczema, or atopic dermatitis
 Eosinophilia, Hypereosinophilic syndrome
 Systemic mastocytosis
 FPIES (food-protein induced enterocolitis)
 Eosinophilic esophagitis
 Hereditary angioedema
 Asthma (NOT other pulmonary diagnoses)

Primary Immunodeficiency –
Indications for Immune Evaluation
 Recurrent/severe cutaneous viral infections (e.g. HSV, molluscum, warts, 
HPV, etc.)
 Recurrent or severe abscess or cellulitis
 Mastoiditis
 Liver, splenic, or lung abscess
 Osteomyelitis
 Sepsis, Bacteremia
 Meningitis
 Recurrent or chronic sinusitis
 Hepatosplenomegaly or lymphadenopathy
 Cytopenias – especially in addition to severe or recurrent infections
 Severe atopic dermatitis – especially in addition to severe/recurrent infections
 Bronchiectasis
 Chronic diarrhea
Pediatric Allergy/Immunology
 Recurrent, severe, or opportunistic infections
 Low IgG, IgA, or IgM, or hypogammaglobulinemia
 Lymphopenia
 Primary immunodeficiency diseases
 Severe combined immunodeficiency disease (SCID)
 22q11.2 deletion syndrome, or DiGeorge syndrome
 Chronic granulomatous disease (CGD)
 Ataxia-telangiectasia
 Hyper IgE syndrome (e.g. Job syndrome)
 Hyper IgM syndrome
 Common variable immunodeficiency disease (CVID)
 X-linked agammaglobulinemia (“Bruton’s agammaglobulinemia”)
 Leukocyte adhesion deficiency 
 Autoimmune lymphoproliferative syndrome (ALPS)
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